Arete Wealth Advisors’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-861
Closed -$38K 537
2023
Q2
$38K Sell
861
-20
-2% -$936 ﹤0.01% 649
2023
Q1
$45K Sell
881
-35
-4% -$2.07K ﹤0.01% 623
2022
Q4
$55.9M Sell
916
-50
-5% -$3.86K ﹤0.01% 600
2022
Q3
$67K Sell
966
-42
-4% -$3.56K 0.01% 553
2022
Q2
$80K Sell
1,008
-108
-10% -$11.7K 0.01% 444
2022
Q1
$168K Sell
1,116
-230
-17% -$34.1K 0.01% 487
2021
Q4
$229K Sell
1,346
-179
-12% -$36K 0.02% 439
2021
Q3
$353K Sell
1,525
-207
-12% -$54.1K 0.04% 302
2021
Q2
$94K Sell
1,732
-85
-5% -$26.6K 0.01% 357
2021
Q1
$633K Buy
+1,817
New +$613K 0.08% 204

Other funds holding CNBS

Arete Wealth Advisors's CNBS Position: Q3 2023 in Review

Arete Wealth Advisors sold out of Amplify Seymour Cannabis ETF (CNBS) in Q3 2023, closing a stake of 861 shares — an estimated $38K sold.

Arete Wealth Advisors first reported a position in CNBS in Q1 2021 and held it in 10 quarters. The position peaked at $55.9M in Q4 2022. 25 funds tracked by Wall St. Rank hold CNBS as of Q3 2023.

  • Arete Wealth Advisors reported no remaining Amplify Seymour Cannabis ETF position as of Q3 2023 after selling out during the quarter.
  • Arete Wealth Advisors sold 861 Amplify Seymour Cannabis ETF shares in Q3 2023, an estimated $38K.
  • Arete Wealth Advisors first reported a position in Amplify Seymour Cannabis ETF in Q1 2021 and held it in 10 quarters.
  • Arete Wealth Advisors's Amplify Seymour Cannabis ETF position peaked at $55.9M in Q4 2022.
  • 25 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q3 2023.

Based on Arete Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.